Ophthalmology

Assigned a PDUFA target date of August 27, 2025, the resubmitted application for the wet AMD treatment will offer another chance for US approval.

Our Q1 2025 recap for ophthalmology spotlights 5 regulatory updates, 5 key trial announcements, and two episodes of our flagship ophthalmology podcast.

Aflibercept 8 mg produced the same or better results compared to other anti-VEGFs while requiring fewer injections.

BRIMOCHOL PF, a combination eye drop for presbyopia, achieved all primary and secondary endpoints in its most recent trial.

Inflammation due to chronic stress may establish connection between food insecurity and other eye diseases

Used as a biomarker across many specialties, the platelet-to-neutrophil ratio may soon enter ophthalmology for diabetic macular edema prediction.

Study indicates pediatric uveitis can occur independent of autoimmune conditions and dupilumab use

Cocoa flavanols can be helpful over a brief period, but after 2 years there is little benefit to risk of age-related macular degeneration.

Blood vessel inflammation directly influences incidence of age-related macular degeneration, epiretinal membrane, retinal vascular occlusion, and central serous chorioretinopathy

Aldeyra announces intention to resubmit NDA with new trial data in mid-year 2025.

The treatment for wet age-related macular degeneration failed to achieve its primary endpoint in both trials.

McCulley examines the latest updates on GLP-1 receptor agonists relevant for ophthalmologists and patients with ophthalmic diseases at TOA 2025.

Follow-up to BALATON/COMINO indicates maintained improvement in best-corrected visual acuity and central subfield thickness 72 weeks after treatment.

Study draws correlative connection between semaglutide and nonarteritic anterior ischemic optic neuropathy, more data required to show causation.

Research presents a correlation between the index and age-related macular degeneration and suggests a causal relationship.

The study proves that cataract, glaucoma, and age-related eye disease can be exacerbated by exposure to several common pollutants simultaneously.

Study finds positive association between weight-adjusted waist index and risk of age-related macular degeneration in adults aged 40 or over.

Hong Kong schoolchildren exhibit increased rates of refractory and corneal astigmatism due to screen exposure during lockdown.

A Q2 2025 preview spotlighting 10 FDA decisions to watch, including upcoming PDUFAs for dupilumab, pz-cel, ketamine, clesrovimab, and more!

The pivotal trial investigating sozinibercept combination therapy failed to meet the primary endpoint of mean change in BCVA at 52 weeks.

Khandelwal discusses advancements in intraocular lens (IOL) categories and the patient's role in choosing more innovative options.

Khandelwal shares insight and key takeaways for the optimization of intraocular lens selection in practice.

Veeral Sheth, MD, is joined by the CEO of Neurotech to discuss the historic approval of revakinagene taroretcel (ENCELTO) for macular telangiectasia type 2.

Repka describes the complications of the US healthcare system and how to advance interactions in advocacy efforts.

Repka dives into the role of advocacy in shaping ophthalmologic policies and ensuring equitable patient care.